Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 6Unknown 3Terminated 3Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 3

Conditions

Hematologic Neoplasms 2Drug-Related Side Effects and Adverse Reactions 2Leukemia 1

Interventions

Cisplatin 352Oxaliplatin 262Capecitabine 258Radiotherapy 240Gemcitabine 223Docetaxel 223Carboplatin 223Cyclophosphamide 219Drug Therapy 218Paclitaxel 205apatinib 201Bevacizumab 195camrelizumab 190Fluorouracil 187sintilimab 133Blood Specimen Collection 125Irinotecan 124Dexamethasone 123Etoposide 119Radiosurgery 118toripalimab 117Surgical Procedures, Operative 115pembrolizumab 110Pemetrexed 108anlotinib 105S 1 (combination) 105Surveys and Questionnaires 101Leucovorin 101Nivolumab 98tislelizumab 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × OTHER × Voriconazole × Clear all
NCT04743544 2021-02-08

Influence of CYP2C19 Genotype on Safety and Efficacy of Voriconazole in Pediatric Patients With Hematologic Malignancy

Dokuz Eylul University

Unknown
62 enrolled
Other hematologic neoplasm

Hematologic Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT04547335 2020-09-16

The Influence of CYP2C19 Polymorphisms on the Safety and Efficacy of Voriconazole

Dokuz Eylul University

Unknown
34 enrolled
Other hematologic neoplasm

Hematologic Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT01501708 2016-05-10

Caspofungin Based Combined Anti-fungal Therapy for Proven or Probable Invasive Fungal Infection

Shanghai Jiao Tong University School of Medicine

Phase 2 Unknown
55 enrolled
Other hematologic neoplasm

Leukemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡